Blue Water Life Science Advisors’s CareDx CDNA Stock Holding History

Blue Water Life Science Advisors’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.9M	Buy	1,190,000 +255,000	+27%	+$5.55M	21.36%	1
2026 Q1	$16.2M	Buy	935,000 +425,000	+83%	+$8.04M	13.02%	3
2025 Q4	$9.61M	Hold	510,000	–	–	6.03%	7
2025 Q3	$7.42M	Sell	510,000 -214,014	-30%	-$3.05M	6.77%	5
2025 Q2	$14.1M	Hold	724,014	–	–	11.2%	4
2025 Q1	$12.9M	Buy	724,014 +120,014	+20%	+$2.58M	12.73%	4
2024 Q4	$12.9M	Hold	604,000	–	–	11.45%	3
2024 Q3	$18.9M	Buy	604,000 +94,000	+18%	+$2.34M	16.59%	2
2024 Q2	$7.92M	Buy	+510,000	New	+$6.16M	7.7%	4
2022 Q3	–	Sell	-275,551	Closed	-$5.92M	–	11
2022 Q2	$5.92M	Sell	275,551 -748,964	-73%	-$20.8M	3.21%	8
2022 Q1	$37.9M	Buy	1,024,515 +179,545	+21%	+$7M	17.99%	3
2021 Q4	$38.4M	Sell	844,970 -75,521	-8%	-$3.94M	11.76%	4
2021 Q3	$58.3M	Buy	920,491 +399,975	+77%	+$30.5M	18.98%	2
2021 Q2	$47.6M	Buy	520,516 +29,000	+6%	+$2.31M	17.93%	2
2021 Q1	$33.5M	Buy	491,516 +64,016	+15%	+$4.97M	16.35%	2
2020 Q4	$31M	Buy	+427,500	New	+$24.8M	18.18%	1

Other funds holding CDNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Blue Water Life Science Advisors's CDNA Position: Q2 2026 in Review

Blue Water Life Science Advisors increased its CareDx (CDNA) stake by 27% in Q2 2026, buying an estimated $5.55M and bringing the position to 1,190,000 shares worth $33.9M. The position accounts for 21.36% of the portfolio, ranked #1.

Blue Water Life Science Advisors first reported a position in CDNA in Q4 2020 and has held it in 16 quarters since. The position peaked at $58.3M in Q3 2021. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

Blue Water Life Science Advisors held 1,190,000 shares of CareDx worth $33.9M as of Q2 2026.
Blue Water Life Science Advisors bought 255,000 CareDx shares in Q2 2026, an estimated $5.55M.
CareDx made up 21.36% of Blue Water Life Science Advisors's portfolio in Q2 2026, its #1 holding.
Blue Water Life Science Advisors first reported a position in CareDx in Q4 2020 and has held it in 16 quarters since.
Blue Water Life Science Advisors's CareDx position peaked at $58.3M in Q3 2021.
227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Blue Water Life Science Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.